Ladenburg Thalmann Financial Services’s Celldex Therapeutics CLDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q4
$2K Sell
1,069
-599
-36% -$1.12K ﹤0.01% 5043
2019
Q3
$4K Buy
1,668
+1,164
+231% +$2.79K ﹤0.01% 4754
2019
Q2
$1K Hold
504
﹤0.01% 5081
2019
Q1
$2K Buy
504
+11
+2% +$44 ﹤0.01% 4912
2018
Q4
$1K Sell
493
-600
-55% -$1.22K ﹤0.01% 5012
2018
Q3
$7K Buy
1,093
+1,066
+3,948% +$6.83K ﹤0.01% 4435
2018
Q2
$1K Hold
27
﹤0.01% 4963
2018
Q1
$1K Hold
27
﹤0.01% 4963
2017
Q4
$1K Hold
27
﹤0.01% 4880
2017
Q3
$1K Hold
27
﹤0.01% 4773
2017
Q2
$1K Sell
27
-58
-68% -$2.15K ﹤0.01% 4710
2017
Q1
$5K Buy
85
+40
+89% +$2.35K ﹤0.01% 4290
2016
Q4
$2K Sell
45
-25
-36% -$1.11K ﹤0.01% 4513
2016
Q3
$4K Buy
70
+13
+23% +$743 ﹤0.01% 4249
2016
Q2
$4K Sell
57
-31
-35% -$2.18K ﹤0.01% 4202
2016
Q1
$5K Sell
88
-16
-15% -$909 ﹤0.01% 4055
2015
Q4
$24K Sell
104
-20
-16% -$4.62K ﹤0.01% 3081
2015
Q3
$20K Buy
124
+38
+44% +$6.13K ﹤0.01% 3097
2015
Q2
$33K Buy
86
+27
+46% +$10.4K ﹤0.01% 2871
2015
Q1
$24K Sell
59
-29
-33% -$11.8K ﹤0.01% 3069
2014
Q4
$24K Buy
88
+80
+1,000% +$21.8K ﹤0.01% 2861
2014
Q3
$1K Sell
8
-197
-96% -$24.6K ﹤0.01% 3785
2014
Q2
$50K Buy
205
+65
+46% +$15.9K ﹤0.01% 2041
2014
Q1
$37K Buy
140
+13
+10% +$3.44K ﹤0.01% 2158
2013
Q4
$46K Sell
127
-703
-85% -$255K ﹤0.01% 1967
2013
Q3
$441K Buy
830
+47
+6% +$25K 0.02% 704
2013
Q2
$183K Buy
+783
New +$183K 0.01% 1011